{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:45:44Z","timestamp":1791297944767,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/ftd.0b013e31817c6bc4","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T09:54:56Z","timestamp":1236246896000},"page":"467-473","source":"Crossref","is-referenced-by-count":30,"title":["Quantification of Citalopram or Escitalopram and Their Demethylated Metabolites in Neonatal Hair Samples by Liquid Chromatography-Tandem Mass Spectrometry"],"prefix":"10.1097","volume":"30","author":[{"given":"Giampietro","family":"Frison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donata","family":"Favretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Vogliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Terranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo Davide","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1517\/13543784.11.10.1477","article-title":"Escitalopram.","volume":"11","author":"Burke","year":"2002","journal-title":"Exp Opin Investig Drugs"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0378-4347(84)80209-1","article-title":"High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients.","volume":"308","author":"Oyehaug","year":"1984","journal-title":"J Chromatogr"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2125.2006.02659.x","article-title":"Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk.","volume":"62","author":"Rampono","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"R4-10-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00004850-199603001-00002","article-title":"Pharmacology and pharmacokinetics of citalopram and other SSRIs.","volume":"11","author":"Baumann","year":"1996","journal-title":"Int Clin Psychopharmacol"},{"key":"R5-10-20210129","first-page":"241","article-title":"Citalopram-a review of pharmacological and clinical effects.","volume":"25","author":"Bezchlibnyk-Butler","year":"2000","journal-title":"J Psychiatry Neurosci"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hup.836","article-title":"Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review.","volume":"22","author":"Bellantuono","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.jp.7211640","article-title":"Necrotizing enterocolitis associated with in utero and breast milk exposure to the selective serotonin reuptake inhibitor, escitalopram.","volume":"27","author":"Potts","year":"2007","journal-title":"J Perinatol"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(95)00347-9","article-title":"Simplified high-performance liquid chromatographic method for the determination of citalopram and desmethylcitalopram in serum without interference from commonly used psychotropic drugs and their metabolites.","volume":"675","author":"Olesen","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0378-4347(01)00305-X","article-title":"High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum.","volume":"761","author":"Tournel","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1570-0232(03)00393-3","article-title":"Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring.","volume":"794","author":"Frahnert","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00007691-199802000-00005","article-title":"I. High-performance liquid chromatography method for analyzing citalopram and desmethylcitalopram from human serum.","volume":"20","author":"Akerman","year":"1998","journal-title":"Ther Drug Monit"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0378-4347(95)00073-R","article-title":"Simultaneous determination of citalopram and its metabolites by high-performance liquid chromatography with column switching and fluorescence detection by direct plasma injection.","volume":"668","author":"Matsui","year":"1995","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0378-4347(99)00352-7","article-title":"Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection.","volume":"734","author":"Kristoffersen","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R15-10-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0378-4347(01)00121-9","article-title":"Rapid determination of citalopram in human plasma by high-performance liquid chromatography.","volume":"755","author":"Macek","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"554","DOI":"10.5414\/CPP40554","article-title":"Simultaneous quantification of citalopram, clozapine, fluoxetine, norfluoxetine, maprotiline, desmethylmaprotiline and trazodone in human serum by HPLC analysis.","volume":"40","author":"Waschgler","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/chromsci\/36.7.365","article-title":"Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography- mass spectrometry.","volume":"36","author":"Eap","year":"1998","journal-title":"J Chromatogr Sci"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1570-0232(04)00605-1","article-title":"Liquid chromatography-positive ion electrospray mass spectrometry method for the quantification of citalopram in human plasma.","volume":"810","author":"Pistos","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jchromb.2005.03.006","article-title":"Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography electrospray ionization mass spectrometry (HPLC-MS\/ESI).","volume":"820","author":"Juan","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2006.05.031","article-title":"Quantitative determination of forty- eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach.","volume":"843","author":"Kirchherr","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.ftd.0000194026.04483.c3","article-title":"A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum.","volume":"28","author":"Sauvage","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1570-0232(04)00703-2","article-title":"Liquid chromatography-electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study.","volume":"811","author":"Singh","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00216-005-3284-3","article-title":"Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.","volume":"382","author":"Salgado-Petinal","year":"2005","journal-title":"Anal Bioanal Chem"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.chroma.2006.06.019","article-title":"Screening of citalopram, fluoxetine and their metabolites in human urine samples by gas chromatography-mass spectrometry. A global robustness\/ruggedness study.","volume":"1123","author":"Berzas Nevado","year":"2006","journal-title":"J Chromatogr A"},{"key":"R25-10-20210129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0379-0738(00)00202-4","article-title":"Identification of selected psychopharmaceuticals and their metabolites in hair by LC\/ESI-CID\/MS and LC\/MS\/MS.","volume":"113","author":"Muller","year":"2000","journal-title":"Forensic Sci Int"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2006.02.019","article-title":"State of the art in hair analysis for detection of drug and alcohol abuse.","volume":"370","author":"Pragst","year":"2006","journal-title":"Clin Chim Acta"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"F98","DOI":"10.1136\/fn.88.2.F98","article-title":"Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse.","volume":"88","author":"Bar-Oz","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R28-10-20210129","first-page":"2139","article-title":"Tobacco, drug and narcotic abuse during pregnancy. Evaluation of in utero exposure by analysis of hair of the neonate.","volume":"21","author":"Kintz","year":"1992","journal-title":"Presse Med"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/FTD.0b013e318067dfe7","article-title":"Highly-specific quantification of ergotamine in urine, blood and hair samples by LC-MS\/MS.","volume":"29","author":"Favretto","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0379-0738(03)00064-1","article-title":"Detection of thiopental and pentobarbital in head and pubic hair in a case of drug-facilitated sexual assault.","volume":"133","author":"Frison","year":"2003","journal-title":"Forensic Sci Int"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/rcm.2485","article-title":"The characterization of selected antidepressant drugs using electrospray ionization with ion trap mass spectrometry and with quadrupole time-of-flight mass spectrometry and their determination by high-performance liquid chromatography\/electrospray ionization tandem mass spectrometry.","volume":"20","author":"Smyth","year":"2006","journal-title":"Rapid Commun Mass Spectrom"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/01.jcp.0000125680.89843.a6","article-title":"Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response.","volume":"24","author":"Nikisch","year":"2004","journal-title":"J Clin Psychopharmacol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e31817c6bc4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:46Z","timestamp":1786038526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200808000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31817c6bc4","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}